Aviance Capital Management LLC raised its stake in shares of Steris Corp. (NYSE:STE) by 9.7% during the second quarter, Holdings Channel reports. The fund owned 13,856 shares of the company’s stock after buying an additional 1,222 shares during the period. Aviance Capital Management LLC’s holdings in Steris Corp. were worth $953,000 at the end of the most recent quarter.
Several other large investors have also made changes to their positions in STE. Diversified Trust Co acquired a new stake in shares of Steris Corp. during the second quarter valued at approximately $320,000. Pitcairn Co. acquired a new stake in shares of Steris Corp. during the second quarter valued at approximately $414,000. Bank of Montreal Can acquired a new stake in shares of Steris Corp. during the second quarter valued at approximately $22,429,000. Hermes Investment Management Ltd. raised its stake in shares of Steris Corp. by 6.3% in the second quarter. Hermes Investment Management Ltd. now owns 848,936 shares of the company’s stock valued at $58,364,000 after buying an additional 49,956 shares during the last quarter. Finally, LS Investment Advisors LLC raised its stake in shares of Steris Corp. by 73.8% in the second quarter. LS Investment Advisors LLC now owns 5,948 shares of the company’s stock valued at $409,000 after buying an additional 2,526 shares during the last quarter. Institutional investors own 91.58% of the company’s stock.
Steris Corp. (NYSE:STE) traded down 0.14% on Monday, reaching $73.02. The company had a trading volume of 484,285 shares. The company’s 50 day moving average is $71.21 and its 200-day moving average is $70.04. Steris Corp. has a one year low of $61.38 and a one year high of $78.77. The firm has a market capitalization of $6.29 billion, a price-to-earnings ratio of 41.94 and a beta of 1.16.
Steris Corp. (NYSE:STE) last released its quarterly earnings results on Tuesday, August 9th. The company reported $0.79 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.02. Steris Corp. had a return on equity of 10.72% and a net margin of 5.52%. The business had revenue of $638.40 million for the quarter, compared to the consensus estimate of $639.04 million. During the same quarter last year, the business posted $0.62 earnings per share. The company’s revenue for the quarter was up 45.1% on a year-over-year basis. On average, equities research analysts expect that Steris Corp. will post $3.90 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 27th. Shareholders of record on Tuesday, August 30th will be given a dividend of $0.28 per share. This is an increase from Steris Corp.’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Friday, August 26th. This represents a $1.12 dividend on an annualized basis and a yield of 1.53%. Steris Corp.’s dividend payout ratio (DPR) is presently 68.71%.
Several equities research analysts recently commented on the company. Zacks Investment Research lowered Steris Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, September 14th. Northcoast Research upgraded Steris Corp. from a “neutral” rating to a “buy” rating in a research report on Friday, June 3rd.
In other news, VP Sudhir K. Pahwa sold 1,028 shares of Steris Corp. stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $70.13, for a total value of $72,093.64. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Daniel A. Carestio sold 2,681 shares of Steris Corp. stock in a transaction dated Friday, August 12th. The stock was sold at an average price of $71.04, for a total value of $190,458.24. The disclosure for this sale can be found here. 2.52% of the stock is owned by insiders.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.